Gribero 150 mg tvrde kapsule
Name | Gribero 150 mg tvrde kapsule |
---|---|
Marketing Authorisation Number | HR-H-083930069 |
Active Substance | dabigatraneteksilatmesilat |
Composition | jedna tvrda kapsula sadrži 150 mg dabigatraneteksilata u obliku dabigatraneteksilatmesilata |
Pharmaceutical Form | Kapsula, tvrda |
Packaging [MA Number for Packaging] | 10 kapsula u blisteru, u kutiji [HR-H-083930069-01] 30 kapsula u blisteru, u kutiji [HR-H-083930069-02] 60 kapsula u blisteru, u kutiji [HR-H-083930069-03] 100 kapsula u blisteru, u kutiji [HR-H-083930069-04] 180 kapsula u blisteru, u kutiji [HR-H-083930069-05] 200 kapsula u blisteru, u kutiji [HR-H-083930069-06] 10 kapsula u blisteru s jediničnom dozom, u kutiji [HR-H-083930069-07] 20 kapsula u blisteru s jediničnom dozom, u kutiji [HR-H-083930069-08] 30 kapsula u blisteru s jediničnom dozom, u kutiji [HR-H-083930069-09] 50 kapsula u blisteru s jediničnom dozom, u kutiji [HR-H-083930069-10] 60 kapsula u blisteru s jediničnom dozom, u kutiji [HR-H-083930069-11] 100 kapsula u blisteru s jediničnom dozom, u kutiji [HR-H-083930069-12] 180 kapsula u blisteru s jediničnom dozom, u kutiji [HR-H-083930069-13] 200 kapsula u blisteru s jediničnom dozom, u kutiji [HR-H-083930069-14] 180 kapsula (3 pakiranja sa 60 kapsula u blisteru s jediničnom dozom), u kutiji [HR-H-083930069-15] 100 kapsula (2 pakiranja sa 50 kapsula u blisteru s jediničnom dozom), u kutiji [HR-H-083930069-16] 60 kapsula u bočici, u kutiji [HR-H-083930069-17] |
Manufacturer | Salutas Pharma GmbH, Barleben, Njemačka
Pharmadox Healthcare Limited, Paola, Malta |
Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
Marketing Authorisation Date | 23.08.2023 |
MA Period of Validity | 23.08.2028 |
Classification Number | UP/I-530-09/20-01/185 |
Registration Number | 381-12-01/171-23-05 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | B01AE07 |
SmPC | download |
PL | download |
Public Assessment Report | download |
Summary of risk management plan | download |
Educational materials for healthcare professionals |
Vodič za propisivače lijeka pVTE, verzija 6 Vodič za propisivače lijeka pSPAF, DVT, PE, verzija 6 Vodič za propisivače lijeka pVTE pedijatrijska populacija, verzija 2 |
Educational materials for patients / caregivers |
Kartica s upozorenjima za bolesnika |